MCULE-9376236718
- InChIKey:
- SMILES:
- InChI:
- Formula:
Amount | Price
![]() Optimized compound price excluding delivery costs. Please note that automatic quote generation will optimize the total price based on your preferences.
|
Guaranteed purity (%) | Delivery time
![]() Estimated door-to-door delivery time for EU and US customers. It will be refined and optimized during quote generation after the shipping country is specified.
|
|
---|---|---|---|---|
1 mg | 17 USD | 98 | 20 working days | Get Quote |
5 mg | 39 USD | 98 | 20 working days | Get Quote |
10 mg | 61 USD | 98 | 20 working days | Get Quote |
- 1-Click Docking Predict the binding orientation and affinity of the ligand to a target.
- Toxicity checker Searching for substructures commonly found in toxic and promiscuous ligands.
- Property calculator Create a physicochemical property profile for the compound in a second.
- Similarity search Find analogs by similarity search.
- Substructure search Find analogs by substructure search.
Name | File |
---|---|
SDF | MCULE-9376236718.sdf |
SMILES | MCULE-9376236718.smiles |
Standard InChI | MCULE-9376236718.inchi |
InChIKey | MCULE-9376236718.txt |
mcule product ID | Supplier | Catalog | Guaranteed purity (%) | Product matching | Availability |
---|---|---|---|---|---|
P-867634532 | A2B Chem | Predominantly Building Block in stock | 98 | As is | in stock |
P-875799579 | AA Blocks | AA Blocks - in stock | N/A | As is | in stock |
P-869303213 | AK Scientific | Building Blocks | 95 | As is | in stock |
P-903153647 | Aaron Chemicals LLC | Predominantly Building Block | 98 | As is | 3 g |
P-893493655 | Advanced ChemBlocks Inc (AChemBlock) | In stock | 90 | As is | 250 mg |
P-606928546 | AmBeed | In stock | N/A | As is | in stock |
P-489135806 | Amadis Chemical Company Limited | Amadis Chemical General Catalog | 97 | As is | in stock |
P-596967327 | Angene | Building Blocks in stock | 98 | As is | 50 mg |
P-580193937 | Apexbio Technology | Bioactive Compound Library | 98 | As is | in stock |
P-864144692 | AstaTech | In Stock BBs | 95 | As is | in stock |
P-580723018 | BLD pharm | In-stock building blocks | 98 | As is | 122 mg |
P-851278811 | Chemshuttle | On request catalog | 95 | As is | by synthesis |
P-860799213 | Chiralstar | Chiralstar Building Blocks | 98 | As is | in stock |
P-861371593 | Combi-Blocks | Building Block on demand | 95 | As is | by synthesis |
P-579480146 | DC Chemicals Limited | Stock Products | 95 | As is | in stock |
P-500142534 | Excenen | Excenen compounds | 98 | As is | in stock |
P-901410011 | FluoroChem | General BB | N/A | As is | in stock |
P-675215940 | Hangzhou Apichem | Building Blocks in stock | 95 | As is | in stock |
P-596580257 | Key Organics | Building Blocks | 97 | As is | 5 mg |
P-854714045 | MedChemExpress | Screening compounds In stock | 95 | As is | in stock |
P-474027036 | MedKoo | In stock compounds | 95 | As is | in stock |
P-608275410 | Molnova | Stock | 98 | As is | in stock |
P-491405710 | Princeton Biomolecular Research | Building Blocks Synthesis | 95 | As is | by synthesis |
P-579712763 | Selleck Biotechnology GmbH | Product Catalog | N/A | As is | in stock |
P-869126370 | TargetMol | Screening Compounds - synthesis | 95 | As is | by synthesis |
P-892290931 | TargetMol | In Stock BB | 95 | As is | unavailable |
P-888639766 | TargetMol | Screening Compounds - stock amount | 95 | As is | 200 mg |
P-575302178 | eNovation Chemicals LLC | Building Blocks in stock | 95 | As is | in stock |
Property | Value |
---|---|
Components | 1 |
Mass | 412.598 |
logP | 7.6286 |
H-bond acceptors | 3 |
H-bond donors | 1 |
Rotatable bonds | 6 |
PSA | 131.67 |
RO5 violations | 1 |
RO3 violations | 4 |
Refractivity | 119.6019 |
Atoms | 47 |
Rings | 4 |
Heavy atoms | 27 |
Hydrogen atoms | 20 |
Heteroatoms | 6 |
N/O atoms | 3 |
Inorganic atoms | 0 |
Halogen atoms | 0 |
Chiral centers | 1 |
R/S chiral centers | 0 |
Unknown chiral centers | 0 |
Undefined chiral centers | 1 |
Stereo double bonds | 0 |
Cis/trans stereo double bonds | 0 |
Unknown stereo double bonds | 0 |
Undefined stereo double bonds | 0 |